Companies / Oman
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Oman, India Increase Drug Sector Co-operation
February 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
However, the country is committed to providing cost-effective treatments to treat chronic diseases. In view of the growing problem of lifestyle-related illness, Oman's need for affordable drugs is pressing. A new national health survey has found that 11.6% of the adult population suffers from diabetes, with the incidences of hypertension and obesity reported at 33% and 19.1%